Canacol Energy Ltd. To Announce Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 17, 2022; Hold Conference Call on Friday, March 18, 2022

Written by Customer Service on March 7, 2022. Posted in Public Companies.

CALGARY, Alberta, March 07, 2022 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (“Canacol” or the “Corporation”) (TSX:CNE; OTCQX:CNNEF; BVC:CNEC) will announce its fourth quarter and fiscal year 2021 financial results on Thursday, March 17, 2022, after the market closure. Senior Management will hold a Conference Call to discuss results on Friday, March 18, 2022 at 8:00 a.m. MST / 10:00 a.m. ET. The conference call may be accessed by dial in or via webcast: Pre-register for the Conference Call: https://dpregister.com/sreg/10164458/f1e1ffd796 Dial In Toll Free: 1-844-784-1724 Participant International Dial In: 1-412-317-6716 Canada Toll Free: 1-866-450-4696 Colombia Toll Free: 01800-9-156803 UK Toll Free: 08082389064 Webcast link: https://services.choruscall.com/mediaframe/webcast.html?webcastid=q3DaATM8 All...

Standard Lithium to Participate in 34th Annual Roth Conference

Written by Customer Service on March 7, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, March 07, 2022 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), an innovative technology and lithium project development company, will participate in the 34th Annual Roth Conference on March 14-15, 2022. Event: 34th Annual Roth Conference, Dana Point, CA (In person 1:1s)Topic: One-on-one meetingsDate: March 14-15, 2022Time: Throughout the day Management will be hosting one-on-one meetings throughout the day on Monday and Tuesday, March 14-15. Interested investors should contact their Roth representative or Standard Lithium’s IR Team at standardlithium@lhai.com. About Standard Lithium Ltd. Standard Lithium is an innovative technology and lithium development company. The Company’s flagship project is located in southern Arkansas, where...

Ensurge Micropower ASA – Issuance of Shares in connection with Share Consolidation

Written by Customer Service on March 7, 2022. Posted in Public Companies.

Reference is made to the announcement by Ensurge Micropower ASA (the “Company”) on 24 February 2022, wherein the Extraordinary General Meeting approved, inter alia, an authorization to the board to issue shares in connection with the contemplated share consolidation in the Company. Pursuant to the board authorization, which may solely be used to make the total number of shares in the Company dividable by 9, the Company has consequently resolved to increase the Company’s share capital with NOK 0.44 from NOK 210,563,602.48 to NOK 210,563,602.92 by issuance of 4 new shares, each share having a par value of NOK 0.11, for a subscription price per share of NOK 0.11. Upon registration of this share capital increase, the Company’s share capital will be NOK 210,563,602.92 divided into 1,914,214,572 shares, each share having...

Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™

Written by Customer Service on March 7, 2022. Posted in Mergers And Acquisitions.

Conference Call to be Held on March 9, 2022 at 8:30am ET to Discuss Transaction TORONTO, March 07, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the closing of its previously-announced acquisition of Serenity Pharmaceuticals LLC (“Serenity”), including the global rights to its Noctiva™ brand. Serenity, based in Miami, FL, is a specialty pharmaceutical company focused on developing therapies for diseases associated with voiding disorders and had previously been granted approval by the U.S. Food and Drug Administration (FDA) for its Noctiva™ (desmopressin acetate) nasal spray. Additional details of this transaction can be found in the Company’s filings in the US and Canada. Acerus will host an investor call to discuss the acquisition of Serenity on March...

VÍS: Viðskipti stjórnenda 07.03.2022

Written by Customer Service on March 7, 2022. Posted in Public Companies.

Viðskiptin eru liður í ráðstöfun kaupauka samkvæmt kaupaukakerfi VÍS vegna ársins 2021, sem gerir kröfu um að útborguðum kaupauka skuli ráðstafað til kaupa á hlutabréfum í félaginu með þriggja ára lágmarkseignarhaldstíma Sjá tilkynningar í meðfylgjandi viðhengjum: Attachments 22.03.07 Seðlabanki Íslands_tilkynning um viðskipti_BJ 22.03.07 Seðlabanki Íslands_tilkynning um viðskipti_GHH 22.03.07 Seðlabanki Íslands_tilkynning um viðskipti_HB 22.03.07 Seðlabanki Íslands_tilkynning um viðskipti_ARÍ 22.03.07 Seðlabanki Íslands_tilkynning um viðskipti_HH 22.03.02 Seðlabanki Íslands_tilkynning um viðskipti AG

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 7, 2022. Posted in Earnings Releases And Operating Results.

SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, today reported financial results for the three months and full year ended December 31, 2021 and provided an update on its corporate activities and product pipeline. “We made significant progress on several key initiatives during the fourth quarter,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara. “Of particular note is our December 2021 announcement of positive topline results from our pivotal ReSTORE Phase 3 clinical trial of rezafungin as a potential first-line treatment for candidemia and invasive candidiasis, which, combined with the data from the previously completed STRIVE...

Oncternal Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 7, 2022. Posted in Public Companies.

SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report fourth quarter and full year 2021 financial results after the U.S. financial markets close on Thursday, March 10, 2022. Oncternal’s management will host a webcast at 2:00 p.m. PT (5:00 p.m. ET) to provide a comprehensive business update and discuss the Company’s financial results. The live webcast of the call will be available online at investor.oncternal.com and the call will be archived there for at least 30 days. About Oncternal TherapeuticsOncternal Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for the treatment of patients with cancers...

CAPREIT Acquires Luxury Six-Building Québec Portfolio

Written by Customer Service on March 7, 2022. Posted in Public Companies.

TORONTO, March 07, 2022 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today that it has completed the purchase of a six-property luxury portfolio of modern, recently-constructed apartment buildings in Montréal, Laval, Côte Saint-Luc and Saint Hyacinthe, Québec. The portfolio totals 516 residential suites including 44 bachelor, 236 one-bedroom, 211 two-bedroom and 25 three-bedroom apartments as well as three commercial units. The properties, built between 2017 and 2021, were acquired for $281.0 million, funded by CAPREIT’s Acquisition and Operating Facility and the assumption of $55.5 million in mortgages with a weighted average interest rate of 2.75% and 6.5-year term to maturity. The suites range between 687 square feet and 1,056 square feet in size and include...

Kinross announces US$1.0 billion term loan

Written by Customer Service on March 7, 2022. Posted in Public Companies.

TORONTO, March 07, 2022 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX:K; NYSE:KGC) (“Kinross”) announced today that it has arranged a new US$1.0 billion term loan. The three-year term loan will mature on March 7, 2025, has no mandatory amortization payments, and has a flexible repayment schedule. Kinross used the proceeds of the financing to repay amounts drawn under its US$1.5 billion revolving credit facility in connection with the closing of its acquisition of Great Bear Resources Ltd. Joint Lead Arrangers were The Bank of Nova Scotia, HSBC Bank Canada and RBC Capital Markets. About Kinross Gold Corporation Kinross is a Canadian-based senior gold mining company with mines and projects in the United States, Brazil, Russia, Mauritania, Chile, Ghana and Canada. Our focus is on delivering value based on the core principles of...

DallasNews Corporation Announces Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 7, 2022. Posted in Earnings Releases And Operating Results.

DALLAS, March 07, 2022 (GLOBE NEWSWIRE) — DallasNews Corporation (Nasdaq: DALN) today reported fourth quarter 2021 net income of $2.1 million, or $0.40 per share, and an operating loss of $0.7 million. The fourth quarter 2021 net income includes a non-cash pension benefit of $1.0 million and cash proceeds of $1.3 million related to the sale of inactive IP addresses. In the fourth quarter of 2020, the Company reported a net loss of $1.7 million, or $(0.32) per share, and an operating loss of $4.0 million. For the fourth quarter of 2021, on a non-GAAP basis, DallasNews reported operating income adjusted for certain items (“adjusted operating income (loss)”) of $0.3 million, a decrease of $0.2 million when compared to adjusted operating income of $0.5 million reported in the fourth quarter of 2020. The decline is primarily due to...

Day: March 7, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice